Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis

Rahul J Anand1, Jeffrey W Kohler, Jaime A Cavallo

  • 1Division of Pediatric Surgery, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA.

Abstract

Insights

Toll-like receptor-4 (TLR4) enhances macrophage phagocytosis of bacteria in peritoneal sepsis. This TLR4-dependent bacterial clearance suggests potential therapeutic applications for sepsis treatment.

Area of Science:

  • Immunology
  • Microbiology
  • Neonatal Research

Background:

  • Peritoneal sepsis in necrotizing enterocolitis leads to infant mortality due to poor bacterial clearance.
  • Toll-like receptor-4 (TLR4) is identified as an endotoxin (lipopolysaccharide [LPS]) receptor.
  • Impaired bacterial clearance suggests a potential role for TLR4 in regulating peritoneal immune responses.

Purpose of the Study:

  • To investigate the role of TLR4 in bacterial clearance from the peritoneal cavity.
  • To determine if macrophage phagocytosis is a mechanism regulated by TLR4 in peritoneal sepsis.

Main Methods:

  • Induction of peritoneal sepsis in mice with functional (wild-type) or mutant TLR4 using Escherichia coli or LPS.
  • Assessment of macrophage phagocytosis via opsonized red blood cell uptake.
  • Quantification of bacterial clearance by plating peritoneal lavage fluid.

Main Results:

  • LPS significantly enhanced macrophage phagocytosis in TLR4-wild-type mice but not in TLR4-mutant mice.
  • In vitro studies confirmed TLR4's role in enhancing phagocytosis by cultured macrophages.
  • TLR4-wild-type mice exhibited greater bacterial clearance compared to TLR4-mutant mice during sepsis.

Conclusions:

  • TLR4 plays a crucial role in the host response to intraperitoneal E. coli infection.
  • TLR4 mediates bacterial clearance through enhanced macrophage phagocytosis.
  • Targeting TLR4 may offer a therapeutic strategy for peritoneal sepsis.